Cascade Dental Partners

Healthcare · Pacific NW · Active Mandate

Deal Size

$58M

Revenue

$39M

Growth

19%

EBITDA Margin

26%

Ready Now

Sellability Score

81/100

Asset quality, growth, margins

Buyer Readiness

83/100

Buyer universe engagement

Momentum Score

77/100

Process activity and recency

Intelligence Summary

DSO with excellent unit economics. Dental PE is highly active. Multiple buyers in early diligence — process is competitive and timely.

Owner Intelligence Profile

DPS

Dr. Patricia Salerno

Founder & Clinical Director · Age 58 · 19 years in business

Succession Risk

High

Communication Style

Warm, relationship-first, skeptical of finance people. Responds to peers and trusted referrals. Needs to feel understood as a clinician before trusting a banker.

Motivation Profile

Patient Legacy + Retirement Security. Built this for patient care, not profit. Needs assurance that clinical standards will be maintained. Also has real retirement planning needs she does not discuss openly.

Succession Intelligence

Clinician-founder. No clinical successor identified. Associate dentists are employees, not partners. Founder approaching retirement age for a practitioner.

Live Signals

Facebook: increasing posts about travel and personal milestones — life transition signals

Dental association board: stepped back from committee chair role last year

Practice website: updated team page but founder bio now mentions "25 years" framing

LinkedIn: connected with 3 DSO executives in past 6 months — researching options

Situational Triggers

DSO consolidation in Pacific NW accelerating — 3 competitors sold in 18 months

Associate dentist turnover increased last year — operational burden growing

Lease renewals on 4 locations coming up in 14 months — capital decision point

Husband recently retired — household dynamic shifting toward her own transition

Trust-Building Tactics

Reference a specific DSO that has maintained clinical culture post-acquisition

Lead with patient outcomes and clinical standards — not EBITDA

Get a warm introduction through a dental association contact or peer

Mention you have worked with clinician-founders before and understand the difference

Avoid

—

Never lead with financial metrics in early conversations

—

Avoid the word "rollup" — implies commoditization of care

—

Do not push for speed — this founder will walk away from urgency

Recommended First Outreach Script

"Dr. Salerno — I was referred to you by Dr. James Whitfield at Pacific Dental Association, who thought we should connect. I work with a small number of dental founders who are thinking about the next chapter — not selling in the traditional sense, but finding the right partner who can take the operational burden off their plate while protecting what they've built clinically. I've seen what happens when that's done well, and what happens when it isn't. I'd love to buy you coffee and learn more about what you've built over the last 19 years. No agenda beyond that."

Recommended Follow-Up Script

"Dr. Salerno — I mentioned I'd send over some information on how two similar practices handled the transition. Attaching a short summary on Pacific Coast Dental and Evergreen Family Dental — both founder-led, both maintained their clinical directors post-close, both expanded their associate programs. Happy to connect you directly with either founder if that would be useful."

Historical Pattern Match

Pattern Match

Resembles 5 closed deals

Est. Time to Close

5-7 months

Key Risk

Founder may reject PE buyers entirely. S...

Profile matches clinician-founded DSOs with 10+ locations. Average time from first contact to LOI: 6.2 months. Longest segment we track. Key pattern: warm intro essential, 3-4 trust-building touchpoints before process discussion, peer reference closes.

Recommended Buyers

Varsity Healthcare PartnersPE

Varsity dental rollup specialist — perfect fit

Linden CapitalPE

Linden strong healthcare, dental experience

Sentinel CapitalPE

Sentinel proven healthcare services model

Recent Interactions

Linden Capitalloi2024-11-10

Second LOI from Linden. Process is competitive.

Varsity Healthcare Partnersloi2024-11-07

LOI submitted at 9x EBITDA. Competitive.

Linden Capitalmanagement meeting2024-11-05

Site visits completed. Strong conviction.

Sentinel Capitalmanagement meeting2024-11-02

IC approved for further diligence.

Gryphon Investorsnda signed2024-11-01

Gryphon NDA signed on dental platform.

Riverside Companynda signed2024-10-28

CIM reviewed, considering add-on.

Riverside Companyintro call2024-10-20

Riverside reviewing dental add-on opportunity.